Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V77236 | AT-1002 TFA | AT-1002 TFA is a 6-mer synthetic peptide, a tight junction regulator and absorption enhancer. | |
![]() |
V31985 | Gap 26 | 197250-15-0 | Gap 26 is a connexin (connexin) mimetic peptide, consisting of residues 63-75 of the first extracellular loop of connexin 43 (gap junction blocker), and contains the SHVR amino acid (AA) motif. |
![]() |
V76988 | Gap 26 TFA | Gap 26 TFA is a connexin (connexin) mimetic peptide, consisting of residues 63-75 of the first extracellular loop of connexin 43 (gap junction blocker), and contains the SHVR amino acid (AA) motif. | |
![]() |
V31969 | Gap 27 | 198284-64-9 | Gap 27, a synthetic connexin43 mimetic peptide, is a gap junction inhibitor. |
![]() |
V41018 | Peptide5 | 916977-43-0 | Peptide5, a mimetic peptide of connexin 43, reduces swelling, astrogliosis, and neuronal cell death in animals after spinal cord injury. |
![]() |
V76639 | Peptide5 TFA | Peptide5 TFA, a mimetic peptide of connexin 43, reduces swelling, astrogliosis, and neuronal cell death in animals after spinal cord injury. | |
![]() |
V55719 | TAT-Gap19 | 1507930-54-2 | TAT-Gap19 is a Cx mimetic peptide and a specific connexin43 hemichannel (Cx43 HC) inhibitor. |
![]() |
V76451 | TAT-Gap19 TFA | TAT-Gap19 TFA is a Cx mimetic peptide and a specific connexin43 hemichannel (Cx43 HC) inhibitor. | |
![]() |
V4626 | Tonabersat (SB220453) | 175013-84-0 | Tonabersat (also known as SB-220453), a benzopyran derivative, is a novel and potent gap-junction modulator used for the prevention of migraine. |
![]() |
V11781 | Larazotide Acetate | 881851-50-9 | Larazotide Acetate, formerly known as AT-1001, is a novel and synthetic peptide acting as a tight junction regulator and reverses leaky junctions to their normally closed state. |
![]() |
V21513 | Danegaptide (GAP-134) hydrochloride | 943133-81-1 | Danegaptide hydrochloride (GAP-134 and ZP-1609) is a novel,potent, selective andorally bioavailable small molecule gap-junction modifier with a potentialfor thetreatment of atrial fibrillation. |